Early Stage Venture Solarea Bio Raises Series A of $11200000

Table of Contents show

About Solarea Bio

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

Website: Learn more on Solarea Bio’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Amount Raised	11200000 USD
Announced Date	2020-10-19
Equity Only Funding	Yes
Organization Location	Cambridge, Massachusetts, United States, North America
Funding Status	Early Stage Venture
Number of Funding Rounds	2
Lead Investors	Bold Capital Partners, S2G Ventures
Number of Investors	4
Number of Partner Investors	2